Study To Assess FRacTure Healing With SclerosTin Antibody - Hip
Public ClinicalTrials.gov record NCT01081678. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults With a Fresh Unilateral Hip Fracture, Status Post Surgical Fixation
Study identification
- NCT ID
- NCT01081678
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 332 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Romosozumab Drug
Drug
Eligibility (public fields only)
- Age range
- 55 Years to 95 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 19, 2010
- Primary completion
- Jun 29, 2012
- Completion
- May 9, 2013
- Last update posted
- Sep 20, 2022
2010 – 2013
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35294 | — |
| Research Site | Pomona | California | 91767 | — |
| Research Site | Aurora | Colorado | 80012 | — |
| Research Site | Denver | Colorado | 80204 | — |
| Research Site | Indianapolis | Indiana | 46202 | — |
| Research Site | Woodbury | Minnesota | 55125 | — |
| Research Site | St Louis | Missouri | 63110 | — |
| Research Site | Brooklyn | New York | 11220 | — |
| Research Site | Rochester | New York | 14642 | — |
| Research Site | Altoona | Pennsylvania | 16602 | — |
| Research Site | Philadelphia | Pennsylvania | 19104 | — |
| Research Site | State College | Pennsylvania | 16801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01081678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01081678 live on ClinicalTrials.gov.